Prevalence and mortality of ceftazidime/avibactam-resistant KPC-producing Klebsiella pneumoniae bloodstream infections (2018–2022)
Matteo Boattini(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Rossana Cavallo(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Silvia Corcione(University of Turin), Francesco Giuseppe De Rosa(University of Turin), Cristina Costa(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Sara Comini(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Gabriele Bianco(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Paulo Bastos, André Almeida(Hospital de Santa Marta)
European Journal of Clinical Microbiology & Infectious Diseases
November 21, 2023
Cited by 30
Related Papers
Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients With Infections Caused by<i>Klebsiella pneumoniae</i>Carbapenemase–producing<i>K. pneumoniae</i>
|Clinical Infectious Diseases|2018|351
Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase–Producing <i>K. pneumoniae</i> Infections: A Retrospective Observational Multicenter Study
|Clinical Infectious Diseases|2021|264
Invasive Fungal Diseases in Adult Patients in Intensive Care Unit (FUNDICU): 2024 consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM
|Intensive Care Medicine|2024|171
Performance of existing definitions and tests for the diagnosis of invasive aspergillosis in critically ill, adult patients: A systematic review with qualitative evidence synthesis
|Journal of Infection|2020|83
Multi-Criteria Decision Analysis to prioritize hospital admission of patients affected by COVID-19 in low-resource settings with hospital-bed shortage
|International Journal of Infectious Diseases|2020|75